JP Morgan Week and Biotech Showcase can be overwhelming. Back-to-back meetings. High expectations. Very little space to pause. That’s why Ergomed created “The Listening Space”.
During this week, sponsors are not looking for a generalist CRO — they are looking for a partner who understands the scientific, operational, and investor-driven realities of early- and late-stage development. Ergomed works alongside emerging and established biotechs to design and execute clinical programs that stand up to regulatory scrutiny, and operational complexity. We’re here to listen to your perspectives on risk-sharing, smarter trial execution, and partnership models that genuinely support teams under pressure.
Book time in "The Listening Space"
Meet our Experts
Ergomed’s leadership team will be available at Tabletop #T-1 at Biotech Showcase and J.P. Morgan to discuss CRO partnerships, early phase planning, patient recruitment strategy, and more.
Nan Shao
Executive Vice President, Ergomed Consulting
Debra Kientop
Senior Vice President, Strategic Solutions and Patient Centricity
Kailyn Bell
Executive Director, Business Development
Julia Day
Senior Director, Business Development
Lina Svedlund
Director, Business Development
Jonathan Pugh
Account Manager, Sales Development
Let’s discuss your development needs!
Ergomed is a specialty CRO partnering with biotech sponsors to design, execute, and optimize complex clinical trials, including rare disease and advanced therapies. We’ll be attending Biotech Showcase™ 2026 and the J.P. Morgan Healthcare Conference in San Francisco — connect with us to explore how our global expertise can support your development program.
Why Sponsors Choose Ergomed
We help biotech partners and sponsors achieve clinical development goals with:
✔ Rare disease & niche indications expertise
✔ Global site management and patient engagement solutions
✔ Early‑phase to pivotal study execution
✔ Operational strategy, trial design, and regulatory guidance
✔ Flexible, partner‑centric CRO solutions tailored to your development stage
